Subsequent studies by us and other groups showed that tumor cell-derived ILT4 directly regulated their proliferation, invasion, migration and epithelial-mesenchymal transition (EMT) and promoted tumor progression [12–14]. The gene discussed is LILRB2; the disease is neoplasm.